Get in on CureVac N.V’s (CVAC) buy-in window today!

With 1.16 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.79 million shares. The 52-week range on CVAC shows that it touched its highest point at $5.28 and its lowest point at $2.21 during that stretch. It currently has a 1-year price target of $6.77. Beta for the stock currently stands at 2.51.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of CVAC was down-trending over the past week, with a drop of -9.59%, but this was down by -16.67% over a month. Three-month performance surged to 27.91% while six-month performance rose 2.17%. The stock lost -4.90% in the past year, while it has lost -3.23% so far this year. A look at the trailing 12-month EPS for CVAC yields 0.54 with Next year EPS estimates of -0.52. For the next quarter, that number is -0.22. This implies an EPS growth rate of 166.58% for this year and -163.57% for next year. EPS is expected to grow by 38.40% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -23.15%.

Float and Shares Shorts:

At present, 224.34 million CVAC shares are outstanding with a float of 93.63 million shares on hand for trading.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for CVAC since 2 analysts follow the stock currently. There are 2 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $0.85916 being high and $0.71596 being low. For CVAC, this leads to a yearly average estimate of $0.79306. Based on analyst estimates, the high estimate for the next quarter is -$0.16 and the low estimate is -$0.16. The average estimate for the next quarter is thus -$0.16.